Literature DB >> 26016793

Lung cancer risks, beliefs and healthcare access among the underprivileged.

Jean-François Morère1, Jérôme Viguier, Chantal Touboul, Xavier Pivot, Jean-Yves Blay, Yvan Coscas, Christine Lhomel, François Eisinger.   

Abstract

One of the current goals of the French national cancer plan is to reduce healthcare inequalities. This study investigated the potential links between vulnerable social status, exposure to lung cancer risk factors and access to healthcare to highlight ways to improve lung cancer control in this population. The nationwide observational study EDIFICE 3 was carried out through phone interviews of a representative sample of 1603 individuals (age 40-75 years). The EPICES validated questionnaire was used to assess and classify vulnerable respondents. The vulnerable population identified represented 33% of the sample. Compared with nonvulnerable individuals, they had more risk factors for cancer: a higher BMI (26.0 vs. 24.8, P≤0.01), 38% were active smokers (vs. 23%, P≤0.01) with a heavier and longer-lasting tobacco consumption (16.0 cigarettes/day vs. 10.1, P≤0.01 and 29.4 vs. 26.3 years of smoking, P≤0.01) and they were less likely to undertake any physical activities (42 vs. 77%, P≤0.01). They also presented more comorbidities (on average 2.2 vs. 1.8, P≤0.01). Access to healthcare, however, was not discriminatory: vulnerable individuals declared consulting a general practitioner or an oncologist more often than the nonvulnerable subgroup (5.4 vs. 3.7 and 6.7 vs. 2.5 consultations in the previous 12 months, respectively, P≤0.01). Because access to healthcare and screening attendance show no signs of discrimination against vulnerable populations, efforts to reduce inequities in lung cancer control should focus on prevention.

Entities:  

Mesh:

Year:  2015        PMID: 26016793     DOI: 10.1097/CEJ.0000000000000143

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  5 in total

1.  Decline in Cancer Screening in Vulnerable Populations? Results of the EDIFICE Surveys.

Authors:  Jean-François Morère; François Eisinger; Chantal Touboul; Christine Lhomel; Sébastien Couraud; Jérôme Viguier
Journal:  Curr Oncol Rep       Date:  2018-03-05       Impact factor: 5.075

2.  Lung cancer screening with low-dose spiral computed tomography: evidence from a pooled analysis of two Italian randomized trials.

Authors:  Maurizio Infante; Stefano Sestini; Carlotta Galeone; Alfonso Marchianò; Fabio R Lutman; Enzo Angeli; Giuseppina Calareso; Giuseppe Pelosi; Gabriella Sozzi; Mario Silva; Nicola Sverzellati; Silvio Cavuto; Carlo La Vecchia; Armando Santoro; Marco Alloisio; Ugo Pastorino
Journal:  Eur J Cancer Prev       Date:  2017-07       Impact factor: 2.497

3.  Survival inequalities in patients with lung cancer in France: A nationwide cohort study (the TERRITOIRE Study).

Authors:  Christos Chouaïd; Didier Debieuvre; Isabelle Durand-Zaleski; Jérôme Fernandes; Arnaud Scherpereel; Virginie Westeel; Cécile Blein; Anne-Françoise Gaudin; Nicolas Ozan; Soline Leblanc; Alexandre Vainchtock; Pierre Chauvin; François-Emery Cotté; Pierre-Jean Souquet
Journal:  PLoS One       Date:  2017-08-25       Impact factor: 3.240

4.  Factors associated with diagnosis of stages I and II lung cancer: a multivariate analysis.

Authors:  Isabel Cristina Martins Emmerick; Anupama Singh; Maggie Powers; Feiran Lou; Poliana Lin; Mark Maxfield; Karl Uy
Journal:  Rev Saude Publica       Date:  2021-12-17       Impact factor: 2.106

5.  Access to innovative drugs for metastatic lung cancer treatment in a French nationwide cohort: the TERRITOIRE study.

Authors:  Arnaud Scherpereel; Isabelle Durand-Zaleski; François-Emery Cotté; Jérôme Fernandes; Didier Debieuvre; Cécile Blein; Anne-Françoise Gaudin; Charlène Tournier; Alexandre Vainchtock; Pierre Chauvin; Pierre-Jean Souquet; Virginie Westeel; Christos Chouaïd
Journal:  BMC Cancer       Date:  2018-10-22       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.